1. Home
  2. PAHC vs CTKB Comparison

PAHC vs CTKB Comparison

Compare PAHC & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • CTKB
  • Stock Information
  • Founded
  • PAHC 1946
  • CTKB 1990
  • Country
  • PAHC United States
  • CTKB United States
  • Employees
  • PAHC N/A
  • CTKB N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PAHC Health Care
  • CTKB Health Care
  • Exchange
  • PAHC Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • PAHC 700.3M
  • CTKB 718.8M
  • IPO Year
  • PAHC 2014
  • CTKB 2021
  • Fundamental
  • Price
  • PAHC $17.99
  • CTKB $3.77
  • Analyst Decision
  • PAHC Sell
  • CTKB Buy
  • Analyst Count
  • PAHC 4
  • CTKB 2
  • Target Price
  • PAHC $21.00
  • CTKB $7.00
  • AVG Volume (30 Days)
  • PAHC 220.8K
  • CTKB 766.1K
  • Earning Date
  • PAHC 05-07-2025
  • CTKB 05-08-2025
  • Dividend Yield
  • PAHC 2.72%
  • CTKB N/A
  • EPS Growth
  • PAHC 30.53
  • CTKB N/A
  • EPS
  • PAHC 0.48
  • CTKB N/A
  • Revenue
  • PAHC $1,106,080,000.00
  • CTKB $200,453,000.00
  • Revenue This Year
  • PAHC $27.84
  • CTKB $4.02
  • Revenue Next Year
  • PAHC $10.22
  • CTKB $8.47
  • P/E Ratio
  • PAHC $37.78
  • CTKB N/A
  • Revenue Growth
  • PAHC 12.63
  • CTKB 3.85
  • 52 Week Low
  • PAHC $12.30
  • CTKB $3.27
  • 52 Week High
  • PAHC $26.55
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 42.54
  • CTKB 44.22
  • Support Level
  • PAHC $16.16
  • CTKB $3.47
  • Resistance Level
  • PAHC $18.35
  • CTKB $4.05
  • Average True Range (ATR)
  • PAHC 1.14
  • CTKB 0.24
  • MACD
  • PAHC 0.10
  • CTKB 0.05
  • Stochastic Oscillator
  • PAHC 52.97
  • CTKB 64.52

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: